Case Study

Delivering 25% of Total Enrollment for a Phase 3 Rare Disease Trial

Science 37 was the top enrolling site, contributing 25% of all randomized patients nationwide. Through…

Case Study

Enrolling 49% of Total Participants Across 49 States for an Oncology Trial

Science 37 was the top enrolling site, delivering 49% of total study enrollment and outperforming…

Case Study

Improving Enrollment, Retention, and Patient Access Across Complex CNS Indications

Science 37 has successfully supported CNS studies treating patients for Major Depressive Disorder, Narcolepsy, Tay-Sachs…

Case Study

Top Enrolling Site Globally for a Phase 2 Rare Hepatology and Gastroenterology Trial 

Science 37 was the top enrolling site globally in a multinational clinical trial spanning North…

Case Study

Phase 3 Infectious Disease Study: 42% Cohort Enrollment Across 36 States in Just 8 Weeks

Science 37 was the top enrolling site, contributing 42% of total participants across 36 states…

Case Study

Enrolling 100% of Total Participants for a Phase 3 Rare Cardiology Trial

Science 37 enrolled all study participants across 19 U.S. states as a single Direct-to-Patient Site,…

Case Study

Enrolling 72 Patients within 8 Months for a Phase 3 Cardiology Trial

Science 37 supported a Phase 3 atrial fibrillation trial, overcoming strict protocol criteria, an older…

Case Study

Exceeded Contracted Enrollment Goal in Phase 2 Rare Disease Study

As the top enrolling site among 52 research locations, Science 37 enrolled 21% of all…

Scientific Poster

Delivering Results: Science 37’s Direct-to-Patient Site for CNS Trials

Decentralized clinical trials have been widely discussed in recent years; however, Science 37 has extensive…

Case Study

How to Operationalize Respiratory Clinical Trials with the Direct-to-Patient Site

Are you looking to expand patient access for your respiratory clinical trials? Discover how a…

Case Study

Science 37 Enables Real-Time Data Collection in Phase 4 Study

A top pharma sponsor approached Science 37 to conduct a Phase 4 clinical trial for…

Case Study

Science 37 Delivers 96% Patient Retention in Fully Remote Study

Science 37 conducted a fully decentralized trial for patients with systemic lupus erythematosus and sjogren's…